6533b7d5fe1ef96bd126481e
RESEARCH PRODUCT
Evaluation of a Cell-Free Collagen Type I-Based Scaffold for Articular Cartilage Regeneration in an Orthotopic Rat Model.
Anna DolcimascoloCaterina PuglisiGiuseppe MusumeciGiuseppe MusumeciRosalba ParentiGiovanna CalabreseGiovanni LaurettaPaola CastrogiovanniAlessandro CastorinaAlessandro CastorinaMarta Anna SzychlinskaSilvia RavalliClaudia FabbiMichelino Di Rosasubject
Settore BIO/17 - IstologiaPathologymedicine.medical_specialtyScaffoldcartilage tissue engineeringcollagen I-based scaffold02 engineering and technologySOX9lcsh:TechnologyArticle03 medical and health sciencesIn vivoarticular cartilage lesionmedicineGeneral Materials Sciencelcsh:Microscopycartilage regenerationAggrecan03 Chemical Sciences 09 Engineering030304 developmental biologylcsh:QC120-168.850303 health scienceslcsh:QH201-278.5Chemistrylcsh:TCartilageRegeneration (biology)021001 nanoscience & nanotechnologymusculoskeletal systemmedicine.anatomical_structurelcsh:TA1-2040ImmunohistochemistryArticular cartilage lesion; Cartilage regeneration; Cartilage tissue engineering; Collagen i-based scaffold; Orthotopic implantationlcsh:Descriptive and experimental mechanicslcsh:Electrical engineering. Electronics. Nuclear engineeringStem cellorthotopic implantation0210 nano-technologylcsh:Engineering (General). Civil engineering (General)lcsh:TK1-9971description
The management of chondral defects represents a big challenge because of the limited self-healing capacity of cartilage. Many approaches in this field obtained partial satisfactory results. Cartilage tissue engineering, combining innovative scaffolds and stem cells from different sources, emerges as a promising strategy for cartilage regeneration. The aim of this study was to evaluate the capability of a cell-free collagen I-based scaffold to promote cartilaginous repair after orthotopic implantation in vivo. Articular cartilage lesions (ACL) were created at the femoropatellar groove in rat knees and cell free collagen I-based scaffolds (S) were then implanted into right knee defect for the ACL-S group. No scaffold was implanted for the ACL group. At 4-, 8- and 16-weeks post-transplantation, degrees of cartilage repair were evaluated by morphological, histochemical and gene expression analyses. Histological analysis shows the formation of fibrous tissue, at 4-weeks replaced by a tissue resembling the calcified one at 16-weeks in the ACL group. In the ACL-S group, progressive replacement of the scaffold with the newly formed cartilage-like tissue is shown, as confirmed by Alcian Blue staining. Immunohistochemical and quantitative real-time PCR (qRT-PCR) analyses display the expression of typical cartilage markers, such as collagen type I and II (ColI and ColII), Aggrecan and Sox9. The results of this study display that the collagen I-based scaffold is highly biocompatible and able to recruit host cells from the surrounding joint tissues to promote cartilaginous repair of articular defects, suggesting its use as a potential approach for cartilage tissue regeneration.
year | journal | country | edition | language |
---|---|---|---|---|
2020-05-21 |